The present study identified FGD5-AS1 as a novel carcinogenic lncRNA in pancreatic cancer, and partly explained the mechanism of the Wnt/β-catenin pathway dysregulation in pancreatic cancer. The gene discussed is FGD5; the disease is familial pancreatic carcinoma.